BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 18065736)

  • 1. Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?
    Mocellin S; Pilati P; Lise M; Nitti D
    J Clin Oncol; 2007 Dec; 25(35):5649-54. PubMed ID: 18065736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer.
    Mocellin S; Pasquali S; Nitti D
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007823. PubMed ID: 19588444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy.
    Pilati P; Mammano E; Mocellin S; Tessari E; Lise M; Nitti D
    Anticancer Res; 2009 Oct; 29(10):4139-44. PubMed ID: 19846962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview.
    Barber FD; Mavligit G; Kurzrock R
    Cancer Treat Rev; 2004 Aug; 30(5):425-36. PubMed ID: 15245775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatic arterial infusion of low-dose leucovorin/5-FU chemotherapy for unresectable hepatic metastases from colorectal cancer].
    Fujimoto T; Yoshimatsu K; Yokomizo H; Umehara A; Watanabe K; Ohtani T; Matsumoto A; Ohsawa G; Ishibashi K; Ogawa K
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1838-40. PubMed ID: 17212122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.
    Samaras P; Breitenstein S; Haile SR; Stenner-Liewen F; Heinrich S; Feilchenfeldt J; Renner C; Knuth A; Pestalozzi BC; Clavien PA
    Ann Surg Oncol; 2011 Jul; 18(7):1924-31. PubMed ID: 21207165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
    Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
    Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
    Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M
    Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
    Kemeny NE; Niedzwiecki D; Hollis DR; Lenz HJ; Warren RS; Naughton MJ; Weeks JC; Sigurdson ER; Herndon JE; Zhang C; Mayer RJ
    J Clin Oncol; 2006 Mar; 24(9):1395-403. PubMed ID: 16505413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H; Ozaki T; Shiina M
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of hepatic arterial infusion chemotherapy with 5-FU and leucovorin for unresectable liver metastases from colorectal cancer].
    Yamashita K; Urakami A; Kubota H; Nagatsuka R; Murakami H; Kawabe Y; Higashida M; Hirabayashi Y; Mikami Y; Ikeda M; Fuchimoto M; Yamamura M; Oka Y; Okumura H; Iki K; Matsumoto H; Imai S; Hirai T; Tsunoda T
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):71-6. PubMed ID: 18195531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer.
    Kim JC; Kim HC; Lee KH; Yu CS; Kim TW; Chang HM; Ryu MH; Kim JH; Ha HK; Lee MG
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1026-35. PubMed ID: 16724990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of radiofrequency ablation of unresectable metastatic colorectal cancer with hepatic arterial infusion pump chemotherapy.
    Martin RC; Scoggins CR; McMasters KM
    J Surg Oncol; 2006 Apr; 93(5):387-93. PubMed ID: 16550574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy for advanced colorectal cancer.
    Benson AB
    Semin Oncol; 1998 Oct; 25(5 Suppl 11):2-11. PubMed ID: 9786311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatic arterial infusion chemotherapy for colorectal liver metastases].
    Kumada T; Sone Y; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kuzuya T; Nonogaki K; Shimizu J; Yamauti T; Kawase N
    Gan To Kagaku Ryoho; 2004 May; 31(5):700-5. PubMed ID: 15170976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: results of a multi-centric randomized study.
    Fiorentini G; Cantore M; Rossi S; Vaira M; Tumolo S; Dentico P; Mambrini A; Bernardeschi P; Turrisi G; Giovanis P; Guadagni S; Valori V; De Simone M
    In Vivo; 2006; 20(6A):707-9. PubMed ID: 17203750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined chemotherapy with oral leucovorin (LV) + tegafur/uracil (UFT) and hepatic arterial infusion (HAI) therapy for liver metastasis of colorectal cancer].
    Hasegawa S; Matsumoto S; Kawashima K; Fujii H; Hatano E; Satoh S; Ikai I; Shimahara Y
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):1045-9. PubMed ID: 16044971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic chemotherapy for advanced colorectal cancer with liver metastasis].
    Hasuike Y; Takeda Y; Mishima H; Nishishou I; Tsujinaka T; Kikkawa N
    Gan To Kagaku Ryoho; 2002 Jun; 29(6):866-72. PubMed ID: 12090037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intra-arterial (5-FU/FA and FUDR) versus systemic chemotherapy (5-FU/FA) of non-resectable colorectal liver metastases].
    Gassel HJ; Müller HH; Mattes P; Stieger R; Schramm H; Lorenz M
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1458-60. PubMed ID: 9931911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.